Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: Open Label, Blinded Endpoint Assessment Study of AMDX-2011P as a Retinal Tracer in Subjects With Cerebral Amyloid Angiopathy (CAA)
Brief Summary: The purpose of this research study is to assess safety and tolerability of a single intravenous (given through a vein) dose of the investigational retinal tracer AMDX-2011P in patients with cerebral amyloid angiopathy (CAA).